Alors que des législatures adoptent des réformes établissant l’accès légal au cannabis pour des fins autres qu’exclusivement « médicales et scientifiques », les tensions entourant les traités actuels des Nations Unies en matière de drogues et l’évolution des lois et pratiques des États membres continuent de s’intensifier. Comment les gouvernements et les systèmes onusiens pourraient-ils aborder ces tensions croissantes par des moyens qui reconnaissent les changements de politiques en cours et qui aident à moderniser le régime des traités sur les drogues, à proprement parler, et par le fait même à renforcer les piliers onusiens des droits humains, du développement, de la paix et de la sécurité ainsi que de la primauté du droit?
The 7th GIZ/TNI Asian Informal Drug Policy Dialogue was organised in collaboration with the National Authority for Combating Drugs (NACD) of the Cambodian Government. Key issues on the agenda were recent trends in the drug market in the region and the development of effective policy responses. Specific attention went to the implementation of the UN Guiding Principles on Alternative Development in the Asian context, including in the implementation of alternative development programmes in conflict areas. The involvement of affected communities in policy making and project implementation was another important theme that was discussed. A major aim of the dialogue was to look at the state of the Asian drug policy before UNGASS 2016.
As jurisdictions enact reforms creating legal access to cannabis for purposes other than exclusively “medical and scientific,” tensions surrounding the existing UN drug treaties and evolving law and practice in Member States continue to grow. How might governments and the UN system address these growing tensions in ways that acknowledge the policy shifts underway and help to modernize the drug treaty regime itself, and thereby reinforce the UN pillars of human rights, development, peace and security, and the rule of law?
The Transnational Institute (TNI) attended the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. The CND negotiated the outcome document to be approved at the 2016 UNGASS on the world drug problem, to be held on April 19-21 in New York.
The Transnational Institute (TNI) attends the 59th session of the UN Commission on Narcotic Drugs in Vienna from the 14-22nd March. This storify features tweets, blogs and news from the event. Our team in Vienna includes Martin Jelsma, Pien Metaal and Tom Blickman.
This timeline draws on The Rise and Decline of Cannabis Prohibition that described the history of international control, how cannabis was included in the current UN drug control system and the subsequent defections by countries and states that have brought the international treaties to breaking point. As the UN gathers for a special session on drug policy in 2016, TNI is calling for a revision of the treaties to be based on scientific evidence and embodying principles of harm reduction and human rights.
For 37 years Colombia has been spraying chemicals to combat illicit crops, particularly coca. These massive eradication programmes became part of the US-backed 'War on Drugs'. The fumigations are controversial for their proven inefficacy to reduce supply and demand for the use of herbicides such as glyphosate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Drug policy reform is currently higher on the international agenda than it has been in recent memory. With a United Nations General Assembly Special Session (UNGASS) on drugs set for 19-21 April 2016, the prominence of this issue will further increase. Significant legal and policy reforms at the national level have taken place in recent years that pose considerable challenges to the international legal framework for drug control, and beg important questions regarding states’ international legal obligations.
The international drug control regime is facing the most profound challenge of its existence. Member states have for some time been experimenting with new responses to the ‘world drug problem’; however, the advent of legally regulated cannabis markets has resulted in a ratcheting up of these challenges to expose the system to new levels of strain. With the 2016 UN General Assembly Special Session (UNGASS) on the world drug problem fast approaching, how will the international community make use of the opportunity it provides for a free and open debate?
As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
Ketamine is an essential medicine used for anaesthesia. It is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine will leave these populations with no alternative anaesthesia for essential surgery, and will further deepen the already acute crisis of global surgery.